Q2 2018 Holdings
Filed 2018-08-14 | 119 holdings | $3.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $195.2K | 5,025,298 | 0.0% |
| Madrigal Pharmaceuticals, Inc.(MDGL) | COM | 558868105 | $327.0K | 1,169,278 | 0.0% |
| Genomic Health, Inc.(GHDX) | COM | 37244C101 | $695.0K | 13,790,574 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $1.1M | 8,555,894 | 0.0% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $1.2M | 100,000 | 0.0% |
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $1.3M | 180,582 | 0.0% |
| Cellectis S.A.(CLLS) | SPONSORED ADS | 15117K103 | $1.4M | 50,000 | 0.0% |
| Arcus Biosciences, Inc.(RCUS) | COM | 03969F109 | $1.5M | 121,534 | 0.0% |
| Incyte Corporation(INCY) | COM | 45337C102 | $2.3M | 34,251,034 | 0.1% |
| Seattle Genetics, Inc. | COM | 812578102 | $3.4M | 51,046,060 | 0.1% |
| Autolus Therapeutics plc(AUTL) | SPON ADS | 05280R100 | $6.3M | 235,294 | 0.2% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $11.3M | 3,621,962 | 0.3% |
| Cerus Corporation(CERS) | COM | 157085101 | $71.7M | 10,749,937 | 2.1% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $79.7M | 961,754 | 2.3% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $80.3M | 14,012,172 | 2.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $188.7M | 2,837,352 | 5.5% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $415.8M | 27,228,338 | 12.2% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $714.3M | 7,583,084 | 20.9% |
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $1.8B | 11,959,824 | 53.7% |